Visceral larva migrans in immigrants from Latin America

Emerging Infectious Diseases

Volumn 17, Issue 7, 2011, Pages 1263-1265

  Turrientes, Maria Carmen ^a   de Ayala, Ana Pérez ^a   Norman, Francesca ^a   Navarro, Miriam ^a   Pérez Molina, José Antonio ^a   Rodriquez Ferrer, Mercedes ^b   Gárate, Teresa ^b   López Vélez, Rogelio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; HELMINTH ANTIBODY;

ARTICLE; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; EOSINOPHILIA; FEMALE; HUMAN; IMMIGRANT; INCIDENCE; LARVA; MAJOR CLINICAL STUDY; MALE; NEMATODE; PRESCHOOL CHILD; SEROPREVALENCE; SOUTH AND CENTRAL AMERICA; TOXOCARA; TOXOCARIASIS; VISCERAL LARVA MIGRANS SYNDROME;

ADOLESCENT; ADULT; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ANTIBODIES, HELMINTH; CHILD; CHILD, PRESCHOOL; EMIGRANTS AND IMMIGRANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; HUMANS; LARVA MIGRANS, VISCERAL; LATIN AMERICA; LONGITUDINAL STUDIES; MALE; SEROEPIDEMIOLOGIC STUDIES; SPAIN; TOXOCARA;

EID: 79959911797     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1707.101204     Document Type: Article

References (14)

1. Sharghi N, Schantz PM, Caramico L, Ballas K, Teague BA, Hotez PJ, et al. Environmental exposure to Toxocara as a possible risk factor for asthma: a clinic-based case-control study. Clin Infect Dis. 2001;32:e111-6. doi:10.1086/319593
2. Magnaval JF, Glickman LT, Dorchies P, Morassin B. Highlights of human toxocariasis. Korean J Parasitol. 2001;39:1-11. doi:10.3347/kjp.2001.39.1.1
3. Lynch NR, Eddy K, Hodgen AN, Lopez RI, Turner KJ. Seroprevalence of. Toxocara canis infection in tropical Venezuela. Trans R Soc Trop Med Hyg. 1988;82:275-81. doi:10.1016/0035-9203(88)90446-4
4. Colli CM, Rubinsky-Elefant G, Paludo ML, Falavigna DL, Guilherme EV, Mattia S, et al. Serological, clinical and epidemiological evaluation of toxocariasis in urban areas of south Brazil. Rev Inst Med Trop Sao Paulo. 2010;52:69-74.
5. Huerga Aramburu H, Lópéz-Vélez R. Comparative study of infectious diseases in immigrant children from various countries. An Pediatr (Barc). 2004;60:16-21. doi:10.1157/13056006
6. Ishida MM, Rubinsky-Elefant G, Ferreira AW, Hoshino-Shimizu S, Vaz AJ. Helminth antigens (Taenia solium, Taenia crassiceps, Toxocara canis, Schistosoma mansoni, and Echinococcus granulosus) and cross-reactivities in human infections and immunized animals. Acta Trop. 2003;89:73-84. doi:10.1016/j.actatropica.2003.09.005
7. Taylor MR, Keane CT, O'Connor P, Mulvihill E, Holland C. The expanded spectrum of toxocaral disease. Lancet. 1988;331:692-5. doi:10.1016/S0140-6736(88)91486-9
8. Kwon NH, Oh MJ, Lee SP, Lee, BJ, Choi DC. The prevalence and diagnostic value of toxocariasis in unknown eosinophilia. Ann Hematol. 2006;85:233-8. doi:10.1007/s00277-005-0069-x
9. Nasrieh MA, Abdel-Hafez SK. Echinococcus granulosus in Jordan: assessment of various antigenic preparations for use in the serodiagnosis of surgically confirmed cases using enzyme immuno assays and the indirect haemagglutination test. Diagn Microbiol Infect Dis. 2004;48:117-23. doi:10.1016/j.diagmicrobio.2003.09.018
10. Smith H, Holland C, Taylor M, Magnaval J-F, Schantz P, Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol. 2009;25:182-8. doi:10.1016/j. pt.2009.01.006
11. Cooper PJ. Toxocara canis infection an important and neglected risk factor for asthma? Clin Exp Allergy. 2008;38:551-3. doi:10.1111/ j.1365-2222.2008.02934.x
12. Ferreira MU, Rubinsky-Elefant G, de Castro TG, Hoffmann EH, da Silva-Nunes M, Cardoso MA, et al. Bottle feeding and exposure to Toxocara as risk factors for wheezing illness among under five Amazonian children: a population based cross-sectional study. J Trop Pediatr. 2007;53:119-24. doi:10.1093/tropej/fml083
13. Muennig P, Pallin D, Challah C, Khan K. The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States. Epidemiol Infect. 2004;132:1055-63. doi:10.1017/S0950268804003000
14. Suputtamongkol Y, Kungpanichkul N, Silpasakorn S, Beeching NJ. Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. Int J Antimicrob Agents. 2008;31:46-9.